Fabio Kater

Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial

Michiel S. van der Heijden, Matthew D. Galsky, Yohann Loriot et al. · The Lancet Oncology · 2020 · 498 citations · Full text

Medicine, Oncology, Pharmacology +14

Consensus on the Treatment and Follow-Up for Metastatic Castration-Resistant Prostate Cancer: A Report From the First Global Prostate Cancer Consensus Conference for Developing Countries (PCCCDC)

Fernando Cotait Maluf, Felipe Moraes Toledo Pereira, Adriano Gonçalves e Silva et al. · JCO Global Oncology · 2021 · 19 citations · Full text

Medicine, Oncology, Urology +12

Response of fibrinolytic activity to venous occlusion.

A. G. Shaper, N. A. Marsh, Indravadan H. Patel et al. · BMJ · 1975 · 16 citations · Full text

Medicine, Physiology, Hemostasis +9

A multi-centre randomized controlled trial investigating Consolidation Chemotherapy with and without oxaliplatin in distal rectal cancer and Watch & Wait

Angelita Habr‐Gama, Guilherme Pagin São Julião, Cinthia D. Ortega et al. · BMC Cancer · 2023 · 15 citations · Full text

Medicine, Oncology, Surgery +17

Consensus for Treatment of Metastatic Castration-Sensitive Prostate Cancer: Report From the First Global Prostate Cancer Consensus Conference for Developing Countries (PCCCDC)

Fernando Cotait Maluf, Felipe Moraes Toledo Pereira, Pedro Luiz Serrano Usón et al. · JCO Global Oncology · 2021 · 14 citations · Full text

Medicine, Oncology, Urology +17